RotaTeq (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the RotaTeq drug offered from Merck Sharp & Dohme Corp.. This Live Rotavirus Vaccine [EPC],Actively Acquired Immunity [PE],Rotavirus Vaccines [Chemical/Ingredient],Vaccines, Live, Unattenuated [Chemical/Ingredient],Live Rotavirus Vaccine [EPC],Actively Acquired Immunity [PE],Rotavirus Vaccines [Chemical/Ingredient],Vaccines, Live, Unattenuated [Chemical/Ingredient],Live Rotavirus Vaccine [EPC],Actively Acquired Immunity [PE],Rotavirus Vaccines [Chemical/Ingredient],Vaccines, Live, Unattenuated [Chemical/Ingredient],Live Rotavirus Vaccine [EPC],Actively Acquired Immunity [PE],Rotavirus Vaccines [Chemical/Ingredient],Vaccines, Live, Unattenuated [Chemical/Ingredient],Live Rotavirus Vaccine [EPC],Actively Acquired Immunity [PE],Rotavirus Vaccines [Chemical/Ingredient],Vaccines, Live, Unattenuated [Chemical/Ingredient] pharmaceutical is classified as a VACCINE. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | Rotavirus Vaccine, Live, Oral, Pentavalent |
| SUBSTANCE NAME: | HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G2P7(5) STRAIN SC2 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G4P7(5) |
| TYPE: | VACCINE |
| PHARMA CLASS: | Live Rotavirus Vaccine [EPC],Actively Acquired Immunity [PE],Rotavirus Vaccines [Chemical/Ingredient],Vaccines, Live, Unattenuated [Chemical/Ingredient],Live Rotavirus Vaccine [EPC],Actively Acquired Immunity [PE],Rotavirus Vaccines [Chemical/Ingredient],Vaccines, Live, Unattenuated [Chemical/Ingredient],Live Rotavirus Vaccine [EPC],Actively Acquired Immunity [PE],Rotavirus Vaccines [Chemical/Ingredient],Vaccines, Live, Unattenuated [Chemical/Ingredient],Live Rotavirus Vaccine [EPC],Actively Acquired Immunity [PE],Rotavirus Vaccines [Chemical/Ingredient],Vaccines, Live, Unattenuated [Chemical/Ingredient],Live Rotavirus Vaccine [EPC],Actively Acquired Immunity [PE],Rotavirus Vaccines [Chemical/Ingredient],Vaccines, Live, Unattenuated [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2006-02-03 |
| END MARKETING DATE: | 0000-00-00 |
RotaTeq VACCINE Details:
| Item Description | RotaTeq from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2200000; 2800000; 2200000; 2000000; 2300000([iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL; [iU]/2mL) |
| START MARKETING DATE: | 2006-02-03 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-4047_f4fa79ca-b0fe-49bc-9c58-8b85032b9f7f |
| PRODUCT NDC: | 0006-4047 |
| APPLICATION NUMBER: | BLA125122 |
Other HUMAN ROTAVIRUS A TYPE G1P7(5) STRAIN WI79 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G2P7(5) STRAIN SC2 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G3P7(5) STRAIN WI78 LIVE ANTIGEN; HUMAN ROTAVIRUS A TYPE G4P7(5) Pharmaceutical Manufacturers / Labelers:
